Valeriana officinalis L. s.l.


  • Andreatini R Leite JR (1994) Effect of valepotriates on the behavior of rats in the elevated plus- maze during diazepam withdrawal. Eur J Pharmacol 260(2-3):233-5
  • Bos, R, Woerdenbag HJ, De Smet PAGM, e Scheffer JJC (1997) Valeriana Species. In: PAGM De Smet, K, Keller, R, Hansel, RF Chandler (Eds.) Adverse effects of herbal drugs Vol. 3. Springer-Verlag Berlin. Pp. 165-179
  • Buchbauer G Jager W Jirovetz L Meyer F Dietrich H (1992) [Effects of valerian root oil, borneol, isoborneol, bornyl acetate and isobornyl acetate on the motility of laboratory animals (mice) after inhalation] Wirkungen von Baldrianol, Borneol, Isoborneol, Bornylacetat und Isobornylacetat auf die Motilitat von Versuchstieren (Mausen) nach Inhalation. Pharmazie 47(8):620-2
  • Cao B Hong GX (1994) Central inhibition action of Valeriana jatamansii Jones] Chung Kuo Chung Yao Tsa Chih 19(1):40-2, 63
  • Cavadas C Araujo I Cotrim MD Amaral T Cunha AP Macedo T Ribeiro CF (1995) In vitro study on the interaction of Valeriana officinalis L. extracts and their amino acids on GABAA receptor in rat brain. Arzneimittelforschung 45(7):753-5
  • Chan TY Tang CH Critchley JA (1995) Poisoning due to an over-the-counter hypnotic, Sleep-Qik (hyoscine, cyproheptadine, valerian). Postgrad Med J 71(834):227-8
  • Cott J (1995) NCDEU update. Natural product formulations available in europe for psychotropic indications. Psychopharmacol Bull 31(4):745-51
  • Dunaev VV Trzhetsinskii SD Tishkin VS Fursa NS Linenko VI (1987) [Biological activity of the sum of the valepotriates isolated from Valeriana alliariifolia] Biologicheskaia aktivnost' summy valepotriatov, vydelennykh iz valeriany chesnochnikolistnoi. Farmakol Toksikol 50(6):33-7
  • Fehri B Aiache JM Boukef K Memmi A Hizaoui B (1991) [Valeriana officinalis and Crataegus oxyacantha: toxicity from repeated administration and pharmacologic investigations] Valeriana officinalis et Crataegus oxyacantha: toxicite par administrations reiterees et investigations pharmacologiques. J Pharm Belg 46(3):165-76
  • Fluckiger, F. & Hanbury, D. (1885) Pharmacographia - The History of the Principle Drugs of Vegetable Origin. Reprinted Delhi (1986)
  • Gerhard U Hobi V Kocher R Konig C (1991) [Acute sedative effect of a herbal relaxation tablet as compared to that of bromazepam] Die sedative Akutwirkung eines pflanzlichen Entspannungsdragees im Vergleich zu Bromazepam. Schweiz Rundsch Med Prax 80(52):1481-6
  • Gerhard U Linnenbrink N Georghiadou C Hobi V (1996) [Vigilance-decreasing effects of 2 plant-derived sedatives] Vigilanzmindernde Effekte zweier pflanzlicher Schlafmittel. Schweiz Rundsch Med Prax 85(15):473-81
  • Hazelhoff B Malingre TM Meijer DK (1982 Jun) Antispasmodic effects of valeriana compounds: an in-vivo and in-vitro study on the guinea-pig ileum. Arch Int Pharmacodyn Ther 257(2):274-87
  • Leathwood PD Chauffard F Heck E Munoz-Box R (1982) Aqueous extract of valerian root (Valeriana officinalis L.) improves sleep quality in man. Pharmacol Biochem Behav 17(1):65-71
  • Leuschner J Muller J Rudmann M (1993) Characterisation of the central nervous depressant activity of a commercially available valerian root extract. Arzneimittelforschung 43(6):638-41
  • Lindahl O Lindwall L (1989) Double blind study of a valerian preparation. Pharmacol Biochem Behav 32(4):1065-6
  • Lovkova MIa Buzuk GN Sokolova SM Kliment'eva NI Ponomareva SM Shelepova OV
  • Nishiya K Kimura T Takeya K Itokawa H (1992) Sesquiterpenoids and iridoid glycosides from Valeriana fauriei. Phytochemistry 31(10):3511-4
  • Oshima Y Matsuoka S Ohizumi Y (1995) Antidepressant principles of Valeriana fauriei roots. Chem Pharm Bull (Tokyo) 43(1):169-70
  • Pank F Hannig HJ Hauschild J Zygmunt B (1980) [Chemical weed control in the cropping of medicinal plants. Part 1: Valerian (Valeriana officinalis L.) (author's transl)] Chemische Unkrautbekampfung in Arzneipflanzenkulturen. 1. Mitteilung: Baldrian (Valeriana officinalis L.). Pharmazie 35(2):115-9
  • Sakamoto T Mitani Y Nakajima K (1992) Psychotropic effects of Japanese valerian root extract. Chem Pharm Bull (Tokyo) 40(3):758-61
  • Santos MS Ferreira F Cunha AP Carvalho AP Ribeiro CF Macedo T (1994) Synaptosomal GABA release as influenced by valerian root extract-- involvement of the GABA carrier. Arch Int Pharmacodyn Ther 327(2):220-31
  • Schulz H Stolz C Muller J (1994) The effect of valerian extract on sleep polygraphy in poor sleepers: a pilot study. Pharmacopsychiatry 27(4):147-51
  • Stevens, P.F. (2001 onwards). Angiosperm Phylogeny Website. Version 5, May 2004 [and more or less continuously updated since].
  • Tittel G Wagner H (1978) [High-performance liquid chromatographic separation and quantitative determination of valepotriates in valeriana drugs and preparations (author's transl)] Hochleistungsflussigchromatographische Trennung und quantitative Bestimmung von Valepotriaten aus Valeriana-Drogen und Zubereitungen. J Chromatogr 148(2):459-68
  • Tufik S Fujita K Seabra M de L Lobo LL (1994) Effects of a prolonged administration of valepotriates in rats on the mothers and their offspring. J Ethnopharmacol 41(1-2):39-44
  • Violon C Van Cauwenbergh N Vercruysse A (1983) Valepotriate content in different in vitro cultures of Valerianaceae and characterization of Valeriana officinalis L. callus during a growth period. Pharm Weekbl [Sci] 5(5):205-9
  • Vorotnitskaia IE (1996) [Medicinal plants--concentrators of chromium. The role of chromium in alkaloid metabolism] Lekarstvennue rasteniia--kontsentratory khroma. Rol' khroma v metabolizme alkaloidov. Izv Akad Nauk Ser Biol (5):552-64
  • Willey LB Mady SP Cobaugh DJ Wax PM (1995) Valerian overdose: a case report. Vet Hum Toxicol 37(4):364-5
  • Yang GY Wang W (1994) [Clinical studies on the treatment of coronary heart disease with Valeriana officinalis var latifolia] Chung Kuo Chung Hsi I Chieh Ho Tsa Chih 14(9):540-2